UK markets close in 1 hour 34 minutes

SI-BONE, Inc. (SIBN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.27-0.01 (-0.07%)
As of 09:52AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close14.28
Open14.30
Bid14.08 x 200
Ask14.33 x 200
Day's range14.10 - 14.37
52-week range13.34 - 29.51
Volume49,215
Avg. volume398,880
Market cap587.993M
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

    SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the first cases completed with the smaller, 9.5 mm diameter, iFuse Bedrock Granite® Implant (Granite 9.5). When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion. This mileston

  • GlobeNewswire

    SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

    Annual guidance increased to $164 million - $166 million, implying annual growth of ~18% - 20%SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $37.9 million, representing growth of ~16%U.

  • GlobeNewswire

    SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

    SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 14, at 2:20 p.m. Eastern Time / 11:20 a.m. Pacific Time. Investors interested in listening to the conference call may do so by